Data shows negative association of CYP1B1 with doxorubicin based chemotherapy induced N-HEM toxicity including mucositis andperipheral neuropathy in paclitaxel based chemotherapy in breast cancer patients of the selected population. This evidence concerns the gene CYP1B1 and breast cancer.